Johnson & Johnson Corp. brought in about $20.2 billion in sales for 4Q17, beating Wall Street consensus of $20.08 billion. One of the bright spots for Brunswick, N.J.-based Johnson & Johnson was the continued improvement of its medical device division. In 2017, J&J's device offerings increased in sales by about 8.3 percent and brought in about $7 billion. This exceeded analysts' consensus of $6.9 billion.